Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 2/20 | 0.52 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.52 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.52 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.52 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.52 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.52 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19803821 | 0.82 | GRIN2D (0.41) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL2367422 | 0.81 | MEN1 (0.54) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL2367424 | 0.81 | MEN1 (0.54) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8635101 | 0.81 | MEN1 (0.54) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL8635103 | 0.81 | MEN1 (0.54) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL5551423 | 0.78 | MEN1 (0.47) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL16861633 | 0.77 | GRIN1 (0.52) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| Benzaldehyde Oxime SCHEMBL10332555 | 0.77 | KMT2A (0.57) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL3067089 | 0.77 | MEN1 (0.50) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B | |
| SCHEMBL887433 | 0.77 | MEN1 (0.50) | GRIN2DGRIN3BGRIN1GRIN2AGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638538-A1 | LIQUID RHEOLOGY CONTROL AGENT | BYK-Chemie GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| WO-2024133435-A1 | LIQUID RHEOLOGY CONTROL AGENT | BYK-CHEMIE GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| EP-2998435-B1 | PHOSPHORIC ACID ESTERIFIED CELLULOSE FIBERS AND PRODUCTION METHOD THEREOF | OJI HOLDINGS CORP (JP) | 2021-10-13 | — | — | EP | claimed |
| EP-2592069-B1 | METHOD OF PRODUCING TOLUENEDICARBAMATE AND METHOD OF PRODUCING TOLUENEDIISOCYANATE | MITSUI CHEMICALS INC (JP) | 2019-04-24 | — | — | EP | claimed |
| CN-102933545-B | Method of producing toluene dicarbamate, method of producing toluene diisocyanate, and toluene dicarbamate | MITSUI CHEMICALS INC | 2014-11-12 | — | — | CN | claimed |
| US-8742164-B2 | Method for producing toluenedicarbamate, method for producing toluenediisocyanate, and toluenedicarbamate | MITSUI CHEMICALS, INC. (JP) | 2014-06-03 | — | — | US | claimed |
| US-8580875-B2 | Acrylic emulsion polymers for removable pressure sensitive adhesive applications | ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) | 2013-11-12 | — | — | US | claimed |
| EP-2592069-A1 | METHOD OF PRODUCING TOLUENEDICARBAMATE, METHOD OF PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE | Mitsui Chemicals, Inc. (JP) | 2013-05-15 | — | — | EP | claimed |
| US-20130109881-A1 | METHOD FOR PRODUCING TOLUENEDICARBAMATE, METHOD FOR PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE | MITSUI CHEMICALS, INC. | 2013-05-02 | — | — | US | claimed |
| CN-102933545-A | Method of producing toluene dicarbamate, method of producing toluene diisocyanate, and toluene dicarbamate | MITSUI CHEMICALS INC | 2013-02-13 | — | — | CN | claimed |
| US-6479508-B1 | INHIBITOR OF RNA DEPENDENT RNA POLYMERASE ACTIVITY OF THE ENZYME NS5B ENCODED BY HEPATITIS C VIRUS FOR TREATMENT AND PREVENTION OF HEPATITIS C INFECTIONS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-11-12 | — | — | US | claimed |
| WO-2002085838-A1 | COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2002-10-31 | — | — | WO | claimed |
| US-6448281-B1 | INHIBITORS OF HEPATITIS C VIRUS REPLICATION; TREATMENT OF HEPATITIS C | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-09-10 | — | — | US | claimed |
| US-20020065418-A1 | Inhibitors of hepatitis C virus replication; treatment of hepatitis C | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-05-30 | — | — | US | claimed |
| US-6358975-B1 | ADMINISTERING 3,4-DIHYDRO-5-(4-(1-PIPERIDINYL)-BUTOX)-1 (2H)-ISOQUINOLINONE, A SELECTIVE INHIBITOR OF POLY(ADP-RIBOSE) POLYMERASE FOR PROPHYLAXIS OF NEURAL TISSUE DAMAGE RESULTING FROM ISCHEMIA AND REPERFUSION INJURY OR NEURODEGENERATIVE | JOHNS HOPKINS UNIVERSITY | 2002-03-19 | — | — | US | claimed |
| WO-2002004425-A2 | VIRAL POLYMERASE INHIBITORS | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2002-01-17 | — | — | WO | claimed |
| US-5874444-A | CONTROLLING CELL AGING | GERON CORPORATION (US) | 1999-02-23 | — | — | US | claimed |
| WO-1998027975-A1 | POLY(ADP-RIBOSE) POLYMERASE INHIBITORS TO TREAT DISEASES ASSOCIATED WITH CELLULAR SENESCENCE | GERON CORPORATION (US) | 1998-07-02 | — | — | WO | claimed |
| US-5521315-A | Olefin substituted long chain compounds | CELL THERAPEUTICS, INC. (US) | 1996-05-28 | — | — | US | claimed |
| EP-0638309-A1 | Substances inhibiting proteic adp ribosilation suitable to prevent the diabetes mellitus complications | ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. (IT) | 1995-02-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020065418-A1 | Inhibitors of hepatitis C virus replication; treatment of hepatitis C | HAVCR2, HCCS, ZC3HAV1 | GRIN2D 4626/4885GRIN3B 2732/4885GRIN1 2546/4885 |
| US-20130109881-A1 | METHOD FOR PRODUCING TOLUENEDICARBAMATE, METHOD FOR PRODUCING TOLUENEDIISOCYANATE, AND TOLUENEDICARBAMATE | CPS1, TST, ALKBH3 | GRIN2D 4219/4885GRIN3B 4757/4885GRIN1 4218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.